Life Science Tools Market by Technology, Product, Offerings, Lab Ownership, Lab Size, End-User

Description

List of Tables

[184 Pages Report] The Life Science Tools Market size was estimated at USD 203.93 billion in 2023 and expected to reach USD 226.14 billion in 2024, at a CAGR 11.21% to reach USD 429.19 billion by 2030.

Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.

KEY MARKET STATISTICS
Base Year [2023]	USD 203.93 billion
Estimated Year [2024]	USD 226.14 billion
Forecast Year [2030]	USD 429.19 billion
CAGR (%)	11.21%

Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology

Cell biology technology focuses on studying cells' physiological properties, structure, organelles, interactions, life cycle, division, and apoptosis. This study requires tools essential for research in areas such as cancer, genetic diseases, and drug development. Researchers prioritize high-throughput screening, live cell imaging, and single-cell analysis capabilities when selecting cell biology tools. Genomic technology encompasses the analysis and manipulation of genomes. Tools in this segment enable sequencing, genotyping, gene expression analysis, and more, aiding in the understanding of genetic foundations of diseases, personalized medicine, and biotechnological advancements. Proteomics technology involves the large-scale study of proteomes (the entire set of proteins produced by an organism or system) and their functions. It is fundamental in understanding disease mechanisms, protein interactions, and therapeutic targets.

End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies

Academic research institutes prioritize affordability, versatility, and cutting-edge technology to support a variety of research activities. Their interests span basic research to applied science, necessitating tools that offer precision and reliability. Unlike commercial entities, academic institutes often operate under tighter budget constraints, focusing on equipment that offers both value and versatility. Biotechnology companies work on innovation, requiring state-of-the-art life science tools for R&D purposes, including drug discovery, genomics, and proteomics. Contract research/manufacturing organizations (CROs/CMOs) prioritize efficiency, scalability, and compliance as they handle diverse projects for pharmaceutical and biotech clients. This segment shares similarities with biotech companies regarding the need for high-throughput and compliance-ready equipment but differs in its focus on service breadth, requiring tools that are adaptable to varied client needs. Diagnostic labs emphasize accuracy, reliability, and speed in diagnostics tools to support patient care decisions. Automated systems for high-volume testing and data management systems for patient data are essential. Hospitals require life science tools that integrate seamlessly into patient care workflows. This includes diagnostic equipment, patient monitoring tools, and laboratory instruments that are reliable and easy to use for clinical staff.

Regional Insights

The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Life Science Tools Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnostica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Life Science Tools Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Cell Biology Technology
- Genomic Technology
- Proteomics Technology

Product
- Cell Culture Systems & 3D Cell Culture
  - Media
  - Reagents
  - Sera

Cloning & Genome Engineering
Flow Cytometry
Liquid Chromatography
Mass Spectrometry
Microscopy & Electron Microscopy
Next Generation Sequencing
Nuclear Magnetic Resonance
Nucleic Acid Microarray
Nucleic Acid Preparation
PCR & qPCR
Sanger Sequencing
Transfection Devices & Gene Delivery Technologies

Offerings
- Consumables
- Instrument
- Services

Lab Ownership
- Private
- Public

Lab Size
- Large
- Medium
- Small

End-User
- Academic Research Institutes
- Biotechnology Companies
- Contract Research Organization/ Contract Manufacturing Organization
- Diagnostic Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Life Science Tools Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Life Science Tools Market?

3. What are the technology trends and regulatory frameworks in the Life Science Tools Market?

4. What is the market share of the leading vendors in the Life Science Tools Market?

5. Which modes and strategic moves are suitable for entering the Life Science Tools Market?

Product Code: MRR-22146147729D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing need for efficient tools for early diagnosis of chronic diseases
  - 5.1.1.2. Surge in investments toward biotech R&D activities from government and non-government organizations
  - 5.1.1.3. Applications of genomic and proteomic technologies for precision medicine
- 5.1.2. Restraints
  - 5.1.2.1. High cost of life science tools
- 5.1.3. Opportunities
  - 5.1.3.1. Robust technological advancements in life science tools
  - 5.1.3.2. Rapid progress and development of life-science tools in the single-cell isolation and analysis
- 5.1.4. Challenges
  - 5.1.4.1. Quality control issues associated with life science tools
5.2. Market Segmentation Analysis
- 5.2.1. Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
- 5.2.2. End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
5.3. Market Trend Analysis
- 5.3.1. Increase in life science research activities and ongoing advancements in life science tools in the Americas
- 5.3.2. Growing focus on medical research to alleviate the burden of diseases in the APAC region
- 5.3.3. Government investments and initiatives for the advancement of the healthcare sector in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Life Science Tools Market, by Technology

6.1. Introduction
6.2. Cell Biology Technology
6.3. Genomic Technology
6.4. Proteomics Technology

7. Life Science Tools Market, by Product

7.1. Introduction
7.2. Cell Culture Systems & 3D Cell Culture
7.3. Cloning & Genome Engineering
7.4. Flow Cytometry
7.5. Liquid Chromatography
7.6. Mass Spectrometry
7.7. Microscopy & Electron Microscopy
7.8. Next Generation Sequencing
7.9. Nuclear Magnetic Resonance
7.10. Nucleic Acid Microarray
7.11. Nucleic Acid Preparation
7.12. PCR & qPCR
7.13. Sanger Sequencing
7.14. Transfection Devices & Gene Delivery Technologies

8. Life Science Tools Market, by Offerings

8.1. Introduction
8.2. Consumables
8.3. Instrument
8.4. Services

9. Life Science Tools Market, by Lab Ownership

9.1. Introduction
9.2. Private
9.3. Public

10. Life Science Tools Market, by Lab Size

10.1. Introduction
10.2. Large
10.3. Medium
10.4. Small

11. Life Science Tools Market, by End-User

11.1. Introduction
11.2. Academic Research Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organization/ Contract Manufacturing Organization
11.5. Diagnostic Laboratories
11.6. Hospitals

12. Americas Life Science Tools Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Life Science Tools Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Life Science Tools Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
- 15.3.1. Bruker advances NMR magnet portfolio, innovates in industrial solutions
- 15.3.2. BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
- 15.3.3. UK boosts life science innovation with £277 million funding
- 15.3.4. Illumina, GenoScreen launched next-generation sequencing innovation to eliminate TB
- 15.3.5. Berkeley Lights Completed Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
- 15.3.6. Waters Corporation launched the next generation Alliance iS HPLC System
- 15.3.7. Patient Square Capital Partnered with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities
- 15.3.8. GenScript expands footprint in Singapore to provide premium Gene Synthesis service
- 15.3.9. SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo MS system
- 15.3.10. Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado
- 15.3.11. Cytek Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
- 15.3.12. Tecan collaborates with Element Biosciences to provide benchtop NGS
- 15.3.13. Agilent to collaborate with Quest Diagnostics to extend access to the Agilent Resolution ctDx FIRST Liquid Biopsy test
- 15.3.14. Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
- 15.3.15. Novo Holdings invests in a proteomics technology company, Evosep
- 15.3.16. Agilent Acquired Life Sciences Company Avida Biomed
- 15.3.17. QIAGEN and Helix Launched Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
- 15.3.18. Bruker enters into a strategic partnership with Biognosys
- 15.3.19. Charles River Labs expands CGT capabilities into Cheshire
- 15.3.20. Neogen Launches New Genomic Management Technology
- 15.3.21. MedGenome Raises USD 50M To Map The Human Genome
- 15.3.22. Thermo Fisher Launches Next-Generation Sequencing Platform for Labs

16. Competitive Portfolio

16.1. Key Company Profiles
16.2. Key Product Portfolio